Cordarone Lawsuit

Cordarone, a heart drug that contains the active ingredient amiodarone, has been linked to a wide range of serious complications, including lung problems, liver damage and death. Cordarone lawsuits are now being filed on behalf of patients who were allegedly harmed by the medication.

Cordarone Legal Reviews

Patients treated with Cordarone may be entitled to compensation if they suffered dangerous, life-threatening side effects allegedly related to its use, including:

Pulmonary fibrosis

Pulmonary toxicity

Liver injury

Vision problems/blindness

Worsening arrhythmia

Death

If you would like to discuss your legal options with a qualified attorney, please contact Bernstein Liebhard LLP today by calling (888) 994-5118.

Daughter Files Cordarone Lawsuit Following Father’s Death

In April 2015, the daughter of University of Alabama athletic director Mal Moor filed a wrongful death suite against Wyeth Pharmaceuticals, Inc., the manufacturer of Cordarone, and Par Pharmaceutical Companies, which markets a generic version of amiodarone. The complaint claims that the medication resulted in Moor’s death from pulmonary fibrosis, and accuses Wyeth and Par of systematically ignoring risks associated with the drug.

According to the lawsuit, Moor took amiodarone for 90 days in 2008 to treat an irregular heartbeat. He was later diagnosed with advanced pulmonary fibrosis and died in March 2013. Cordarone and other forms of amiodarone are not approved to treat atrial fibrillation, and are only indicated as “a drug of last resort for patients suffering from documented recurrent life-threatening ventricular fibrillation and ventricular tachycardia.” But the Moor lawsuit claims that the drugs’ manufacturers aggressively marketed Cordarone and amiodarone as a first line treatment for such patients. Read More

Cordarone: What’s the Problem?

Cordarone is an antiarrhythmic agent. While it’s not clear how Cordarone works, it is thought that amiodarone affects a portion of the heart’s electrical activity. In 2004, drugs containing amiodarone were prescribed to approximately 2.3 million patients. It is thought that more than 80% were given the medication for indications other than those it is approved to treat.

December 2011: The FDA advised that Zocor (simvastatin) dosage should not exceed 20 mg when the statin medication is being used in combination with amiodarone. The dosage recommendations were intended to reduce the risk of serious muscle injury (myopathy), including rhabdomyolysis, a condition which can lead to kidney damage, kidney failure and death.

March 2015: The FDA recommended that the hepatitis C medications Harvoni and Sovaldi not be co-administered with amiodarone. The recommendation was based reports of nine severe cases of symptomatic bradycardia (slow heart rate) and one fatal cardiac arrest in individuals caused by amiodarone and Harvoni or amiodarone and Sovaldi plus another direct-acting antiviral.

Injured by Cordarone? Contact an Attorney Today.

Individuals who suffered serious complications allegedly related to Cordarone may be entitled to compensation for medical bills, lost wages, pain and suffering and more. To discuss filing a Cordarone lawsuit with our legal team, please contact Bernstein Liebhard today at (888) 994-5118.

Last Modified: May 9, 2016

Private Case ReviewWere you or a loved one harmed by a prescription drug or medical device? Get a free case review.